000131741 001__ 131741 000131741 005__ 20250923084416.0 000131741 0247_ $$2doi$$a10.1016/j.ijid.2024.01.015 000131741 0248_ $$2sideral$$a137166 000131741 037__ $$aART-2024-137166 000131741 041__ $$aeng 000131741 100__ $$aSoriano, Vicente 000131741 245__ $$aScreening for HTLV-1 infection should be expanded in Europe 000131741 260__ $$c2024 000131741 5060_ $$aAccess copy available to the general public$$fUnrestricted 000131741 5203_ $$aHuman T-cell lymphotropic virus type 1 (HTLV-1) infection is spreading globally at an uncertain speed. Sexual, mother-to-child, and parenteral exposure are the major transmission routes. Neither vaccines nor antivirals have been developed to confront HTLV-1, despite infecting over 10 million people globally and causing life-threatening illnesses in 10% of carriers. It is time to place this long-neglected disease firmly into the 2030 elimination agenda. Current evidence supports once-in-life testing for HTLV-1, as recommended for HIV, hepatitis B and C, along with targeted screening of pregnant women, blood donors, and people who attended clinics for sexually transmitted infections (STIs). Similar targeted screening strategies are already being performed for Chagas disease in some Western countries in persons from Latin America. Given the high risk of rapid-onset HTLV-1-associated myelopathy, universal screening of solid organ donors is warranted. To minimize organ wastage, however, the specificity of HTLV screening tests must be improved. HTLV screening of organ donors in Europe has become mandatory in Spain and the United Kingdom. The advent of HTLV point-of-care kits would facilitate testing. Finally, increasing awareness of HTLV-1 will help those living with HTLV-1 to be tested, clinically monitored, and informed about transmission-preventive measures. 000131741 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000131741 590__ $$a4.3$$b2024 000131741 592__ $$a1.323$$b2024 000131741 591__ $$aINFECTIOUS DISEASES$$b24 / 137 = 0.175$$c2024$$dQ1$$eT1 000131741 593__ $$aInfectious Diseases$$c2024$$dQ1 000131741 593__ $$aMicrobiology (medical)$$c2024$$dQ1 000131741 593__ $$aMedicine (miscellaneous)$$c2024$$dQ1 000131741 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000131741 700__ $$ade-Mendoza, Carmen 000131741 700__ $$aCalderón, E. 000131741 700__ $$aRodríguez-Iglesias, M. 000131741 700__ $$aMontiel, N. 000131741 700__ $$aTrujillo, T. 000131741 700__ $$aViciana, I. 000131741 700__ $$aCabezas, T. 000131741 700__ $$aLozano, A. 000131741 700__ $$aFernández-Fuertes, E. 000131741 700__ $$aFernández, J.M. 000131741 700__ $$aGarcía, F. 000131741 700__ $$aAlvarez, M. 000131741 700__ $$0(orcid)0000-0001-5134-1006$$aBenito, R.$$uUniversidad de Zaragoza 000131741 700__ $$0(orcid)0000-0002-0036-6630$$aAlgarate, S. 000131741 700__ $$aDucons, M. 000131741 700__ $$aOrtega, D.$$uUniversidad de Zaragoza 000131741 700__ $$aCifuentes, C. 000131741 700__ $$aFernández-Baca, V. 000131741 700__ $$aMaciá, M.D. 000131741 700__ $$aHernández-Betancor, A. 000131741 700__ $$aMartín, A.M. 000131741 700__ $$aPena, M.J. 000131741 700__ $$aHernández, M. 000131741 700__ $$aLópez-Lirola, A.M. 000131741 700__ $$aGómez-Sirvent, J.L. 000131741 700__ $$aCopado, R. 000131741 700__ $$aCano, M.E. 000131741 700__ $$aRojo, S. 000131741 700__ $$aEirós, J.M. 000131741 700__ $$aRodríguez, M. 000131741 700__ $$aGómez-Hernando, C. 000131741 700__ $$aGonzález-Praetorius, A. 000131741 700__ $$aRando, A. 000131741 700__ $$aForce, L. 000131741 700__ $$aMiró, E. 000131741 700__ $$aCebollero, A. 000131741 700__ $$aDelgado, J.F. 000131741 700__ $$aRodríguez, G. 000131741 700__ $$aFernández-Pereira, L. 000131741 700__ $$aAguilera, A. 000131741 700__ $$aPereira, S. 000131741 700__ $$aFernández-Montero, J.V. 000131741 700__ $$aGarcía, J. 000131741 700__ $$aArcay, R. 000131741 700__ $$aTrigo, M. 000131741 700__ $$aDiz, J. 000131741 700__ $$aGarcía-Campello, M. 000131741 700__ $$aCortizo, S. 000131741 700__ $$aPérez, S. 000131741 700__ $$aMorano, L. 000131741 700__ $$aReina, G. 000131741 700__ $$aArazamendi, M. 000131741 700__ $$aSalicio, Y. 000131741 700__ $$aUgalde, E. 000131741 700__ $$aNieto, M.C. 000131741 700__ $$aLiendo, P. 000131741 700__ $$aGoikoetxea, A.J. 000131741 700__ $$aOcete, M.D. 000131741 700__ $$aRamos, J.M. 000131741 700__ $$aEscribano, I. 000131741 700__ $$aSauleda, S. 000131741 700__ $$aPirón, M. 000131741 700__ $$aGonzález, R. 000131741 700__ $$aRichart, A. 000131741 700__ $$aBarea, L. 000131741 700__ $$aJiménez, A. 000131741 700__ $$aBlanco, L. 000131741 700__ $$aNavarro, L. 000131741 700__ $$aAyerdi, O. 000131741 700__ $$aBaza, B. 000131741 700__ $$aRodriguez, C. 000131741 700__ $$adel-Romero, J. 000131741 700__ $$aGalar, A. 000131741 700__ $$aAldamiz, T. 000131741 700__ $$aValeiro, M. 000131741 700__ $$aPérez, L. 000131741 700__ $$aRodríguez-Avial, I. 000131741 700__ $$aMartín-Carbonero, L. 000131741 700__ $$aBarreiro, Pablo 000131741 700__ $$aFernández-Ruiz, M. 000131741 700__ $$aParra, P. 000131741 700__ $$aRedondo, N. 000131741 700__ $$aRuiz-Merlo, T. 000131741 700__ $$aPozuelo, M.J. 000131741 700__ $$aTreviño, A. 000131741 700__ $$ade Jesús, F. 000131741 700__ $$aCorral, O. 000131741 700__ $$aSoriano, V. 000131741 700__ $$aPintos, I. 000131741 700__ $$aMoreno-Torres, V. 000131741 700__ $$aBlanco, M. 000131741 700__ $$aHuertas, A. 000131741 700__ $$aVargas-Núñez, J.A. 000131741 700__ $$ade Mendoza, C. 000131741 7102_ $$11011$$2630$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Microbiología 000131741 773__ $$g140 (2024), 99-101$$pInt. j. infect. dis.$$tINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES$$x1201-9712 000131741 8564_ $$s272082$$uhttps://zaguan.unizar.es/record/131741/files/texto_completo.pdf$$yVersión publicada 000131741 8564_ $$s2840366$$uhttps://zaguan.unizar.es/record/131741/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000131741 909CO $$ooai:zaguan.unizar.es:131741$$particulos$$pdriver 000131741 951__ $$a2025-09-22-14:33:06 000131741 980__ $$aARTICLE